Greg Mckee Email & Phone Number

Journey Life Sciences is focused on developing and commercializing therapeutic treatments for chronic pain through the use of psychoactive compounds with the potential to solve the opioid epidemic.

Irving, Texas, US

YPO (formerly Young Presidents' Organization) is an American-based worldwide leadership community of chief executives with more than 34,000 global members in more than 142 countries.

The Modern Health Alliance (MHA) was an advocacy organization championing the benefits of new medicines. We do this by supporting legislation + policies that promote research, education and product development.

Raleigh, NC, US

Bonaventure Equity is a life sciences venture capital firm investing in cannabinoid and psychedelic innovation. BVE partners with dynamic founders and management teams at the forefront of scientific breakthroughs on the path to commercialization.

Numinus is an integrated mental health company creating an ecosystem of health solutions to research, develop, and deliver safe, evidence-based, accessible psychedelic-assisted psychotherapy.

Melbourne, Victoria, AU

Publicly-traded CSE: TRYP is a clinical stage pharmaceutical company leading psychedelic drug development beyond mental health.

Melbourne, Victoria, AU

Torrent Ventures supports companies pursuing the most dynamic healthcare and medical technology opportunities. The firm has deep relationships with corporate and academic centers of innovation for drug development, genomics, diagnostics, medical devices and precision medicine technologies.

San Diego, CA, US

CONNECT is a southern California based business accelerator focused on creating and scaling technology and life science start-ups. Initially affiliated with the University of California, San Diego, CONNECT has served over 4,000 companies which have raised over $1.2 billion. CONNECT Springboard graduate companies are on track to generate over $500 million.

US

Akela Pharma Inc. was an Austin, Texas based, Toronto Stock Exchange listed (AKL:TO) drug development company and contract manufacturing organization Akela’s lead compound, Fentanyl TAIFUN, was a Phase 3 ready, novel, inhaled version of Fentanyl being developed for break-through cancer pain. Akela’s, CMO, PharmaForm, had capabilities to manufactures Phase.

US

Nventa Biopharmaceuticals Corporation was a development stage drug development company focusing on developing innovative therapeutic vaccines for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV). The Company’s lead candidate, HspE7, was a novel therapeutic vaccine intended for the treatment of.

US

US

Valentis was a biopharmaceutical company with a significant body of non-viral gene delivery patents used in combination with specific genes to treat Cardiovascular disease and certain oncology indications.

Paris, France, FR

Director - Asia Genzyme International (Singapore)Based in Singapore, responsible for the overall business strategy and implementation for the Company’s South East Asia region for the Therapeutics and BioSurgical Products business units. Lead multinational team with highly diverse backgrounds, including one PhD, one Korean, one Taiwanese, one Australian.

Paris, France, FR

Paris, France, FR

Employed by The Honorable Taro Nakayama immediately following his reign as Minister for Foreign Affairs of Japan. Served as the only non-Japanese member of staff, with main oversight of the Minister’s international portfolio, including advising the United Nations sponsored Inter-Action Council; developing the International Medical Parliamentarians.

Zurich, CH

First member of Japanese derivative product sales and trading team and one of eight on Japanese Equity desk in UBS Warburg’s Tokyo-based investment banking operation. Responsible for establishing relationships and generating sales and trading revenues from non-Japanese based investors in Tokyo, Hong Kong, and New York. Assisted in the development of the.

Tokyo, Japan, JP

First non-Japanese staff member of the Japanese Equity Desk within the Company’s Pension Fund Management Department, responsible for the management of Japanese equity portfolios valued at $550 million.

Tokyo, Japan, JP

Mba, Finance/Entrepreneurial Management

Ma, International Studies - Concentration In Asia Studies And Japanese Language

Ba, Economics